Theriva (TOVX) Gains Traction In Pre-Market Following Trial Update
Fahim Awan
May 7, 2025
Theriva Biologics, Inc. (NYSE: TOVX) shares are significantly gaining traction on the charts during pre-market session today, up 62.5% to $2.21 as of the last